Physician profile
Eugene T Bode
NPI 1548210909
$1,047.73
in general payments reported to CMS, 2019-2025
16 companies · $63.17 in 2025
The $63.17 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $58.84 · 2022: $76.33 · 2023: $336 · 2024: $513 · 2025: $63.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $897 · Education: $15.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $896.63 |
| Education | $15.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $263.40 | 2021-2025 | Entyvio, Eohilia |
| Janssen Biotech, INC. | $111.54 | 2023-2024 | Stelara, Remicade, Simponi Aria |
| Ardelyx, INC. | $96.46 | 2023-2024 | Ibsrela |
| Qol Medical, LLC | $85.83 | 2023-2025 | Sucraid, Sucraid |
| Abbvie INC. | $79.58 | 2024-2025 | |
| Aimmune Therapeutics, INC. | $74.77 | 2024 | |
| Nestle Healthcare Nutrition INC. | $62.73 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $61.69 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $51.52 | 2021-2024 | Dificid |
| Organon LLC | $42.99 | 2023-2024 | Renflexis, Hadlima |
| Lilly USA, LLC | $28.16 | 2024 | Omvoh |
| Ucb, INC. | $25.19 | 2024 | Cimzia |
| Intercept Pharmaceuticals, INC. | $16.49 | 2023 | Ocaliva |
| Celltrion USA INC. | $15.93 | 2024 | Zymfentra |
| Braintree Laboratories, INC. | $15.90 | 2024 | Suflave, Sutab |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $15.55 | 2023 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Bode listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.